Stuart Poulton and Patricia Judson (Karyopharm)

As long­time CMO ex­its, Karyopharm taps Big Phar­ma vets to steer can­cer drug fran­chise

As Richard Paul­son con­tin­ues to make a case for the Xpovio fran­chise, he will be sur­round­ing him­self with a new clin­i­cal team at Karyopharm. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.